Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing capsule for hospitalized patients with acute exacerbation of mild to moderate COPD
ChiCTR2000031080Phase 4Not yet recruiting
- Sponsor
- Shuguang Hospital
- Start
- Mar 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tanreqing in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Shuguang Hospital. Primary endpoints: TCM clinical syndrome index and Dyspnea, cough and expectoration scale. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
tanreqing
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2000031080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031080.